Active ingredients: fluticasone furoate + vilanterol
What it is used for
COPD,Breo Ellipta is indicated for symptomatic treatment of patients with COPD with a FEV1 <70% predicted normal (post-bronchodilator) in patients with an exacerbation history despite regular bronchodilator therapy.,Breo Ellipta is not indicated for the initiation of bronchodilator therapy in COPD.,Asthma,Breo Ellipta is indicated in the regular treatment of moderate to severe asthma in patients who require a medium to high dose inhaled corticosteroid combined with a long-acting beta-2-agonist.,Vilanterol, an active ingredient in Breo Ellipta, is a long-acting beta-2-agonist (LABA). A class effect of all LABAs can be an increased risk of asthma death (see Precautions).
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Inhalation
- Store below 30 degrees Celsius
- See Product information for shelf life
- Lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
A plastic inhaler with light grey body, pale blue mouthpiece cover and a dose counter, containing two strips of blisters each containing a white powder
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient fluticasone furoate + vilanterol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)
Breo Ellipta 100/25 Powder for inhalation - myDr.com.au
Breo Ellipta 100/25 Powder for inhalation - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Breo Ellipta | myVMC
Fluticasone furoate 100 or 200 micrograms and vilanterol (as trifenatate) 25 micrograms per inhalation
Read more on myVMC – Virtual Medical Centre website